Pfizer pouring COVID profits into cancer battle, CEO Bourla says
Pfizer Inc PFE.N is pouring the windfall profits from its COVID-19 vaccine and treatment into developing products to battle cancer, most notably in its $43 billion purchase of Seagen Inc SGEN.O, Chief Executive Albert Bourla said at a Reuters newsmaker event on Thursday. “Pfizer is giving all the profits that we made from COVID in […]
Continue Reading